Apr 12,2022

Diabeloop adapts its self-learning, personalized insulin automatization software to be used with insulin pens

Diabeloop announced today that it leveraged its diabetes management software to integrate insulin pens into its hybrid closed-loop system.

PRODUCT

#connected device

#closed loop

View Analyst & Ambassador Comments
Go to original news
Apr 13,2022

Brighter Publishes the Annual Report for the Financial Year 2021

Brighter AB [publ], has today published the company’s Annual Report for the Fiscal Year 2021.

View Analyst & Ambassador Comments
Go to original news
Apr 13,2022

Dexcom announces availability of G6 for Tricare members as formulary pharmacy benefit

Dexcom (Nasdaq:DXCM) announced that its G6 continuous glucose monitoring (CGM) system will be available through Tricare.

PRODUCT

#cgm

View Analyst & Ambassador Comments
Go to original news
Apr 14,2022

DarioHealth Announces Agreement with Health Plan Colorado Access

DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today a new agreement with Colorado Access, the largest public sector health plan in the state of Colorado, to provide digital chronic condition management solutions for its Medicaid population beginning with thousands of its members in the second quarter of 2022.

COLLABORATION PARTNERSHIP

#insurance

View Analyst & Ambassador Comments
Go to original news
Apr 19,2022

How Insulet created its next-gen Omnipod 5

Insulet CEO Shacey Petrovic will present at DeviceTalks Boston on May 10-11, 2022 as a keynote speaker.

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Apr 19,2022

Improving the use of DTx in behavioural health

By Dr. Arbinder Singal, MBBS (Gold Medalist), DNB, M. Ch (AIIMS, Gold Medalist), CEO & Co-founder, Fitterfly

View Analyst & Ambassador Comments
Go to original news
Apr 20,2022

Levels $38M Series A Driven by Member and Community Alignment to Solve Metabolic Health Crisis

Levels, a software company that gives you real-time feedback on how food affects your health, today announced a $38 million Series A alongside a $300 million valuation to continue its mission of solving the metabolic health crisis.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Apr 20,2022

Abbott Diabetes Care REPORTS FIRST-QUARTER 2022 RESULTS

In Diabetes Care, FreeStyle Libre sales were approximately $1.0 billion in the quarter, which represents sales growth of 20.4 percent on a reported basis and 26.2 percent on an organic basis.

View Analyst & Ambassador Comments
Go to original news
Apr 22,2022

KidsAP Study Shows Huge Benefit with Closed-Loop System for Children's Diabetes Self-Management

The KidsAP project, a 5-year EU-funded international collaboration aiming to assess the ability of closed-loop therapy to improve glucose control in very young children with type 1 diabetes, is now completed.

CLINICAL STUDY

#closed loop

View Analyst & Ambassador Comments
Go to original news
Apr 24,2022

Strengths and Challenges of Closed-Loop Insulin Delivery During Exercise in People With Type 1 Diabetes: Potential Future Directions

Closed-loop (CL) systems have shown benefit in the overall glycemic management of type 1 diabetes, including improving HbA1c levels and reducing the incidence of nocturnal hypoglycemia; however, these systems are challenged by the rapidly changing insulin needs with exercise.

CLINICAL STUDY

#closed loop

View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES